- Home
- CRNT vs ATYR Comparison
CRNT vs ATYR Comparison
Compare CRNT & ATYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRNT
- ATYR
- Stock Information
- Founded
- CRNT 1996
- ATYR 2005
- Country
- CRNT Israel
- ATYR United States
- Employees
- CRNT N/A
- ATYR N/A
- Industry
- CRNT Radio And Television Broadcasting And Communications Equipment
- ATYR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CRNT Technology
- ATYR Health Care
- Exchange
- CRNT Nasdaq
- ATYR Nasdaq
- Market Cap
- CRNT 303.2M
- ATYR 330.7M
- IPO Year
- CRNT 2000
- ATYR 2015
- Fundamental
- Price
- CRNT $2.59
- ATYR $3.87
- Analyst Decision
- CRNT Strong Buy
- ATYR Strong Buy
- Analyst Count
- CRNT 5
- ATYR 6
- Target Price
- CRNT $6.15
- ATYR $18.60
- AVG Volume (30 Days)
- CRNT 1.7M
- ATYR 2.1M
- Earning Date
- CRNT 05-06-2025
- ATYR 03-13-2025
- Dividend Yield
- CRNT N/A
- ATYR N/A
- EPS Growth
- CRNT 285.71
- ATYR N/A
- EPS
- CRNT 0.27
- ATYR N/A
- Revenue
- CRNT $394,190,000.00
- ATYR $235,000.00
- Revenue This Year
- CRNT $3.36
- ATYR $1,387.23
- Revenue Next Year
- CRNT $7.39
- ATYR $873.22
- P/E Ratio
- CRNT $9.70
- ATYR N/A
- Revenue Growth
- CRNT 13.54
- ATYR N/A
- 52 Week Low
- CRNT $2.33
- ATYR $1.42
- 52 Week High
- CRNT $5.73
- ATYR $4.66
- Technical
- Relative Strength Index (RSI)
- CRNT 33.95
- ATYR 54.43
- Support Level
- CRNT $2.36
- ATYR $2.98
- Resistance Level
- CRNT $2.81
- ATYR $4.32
- Average True Range (ATR)
- CRNT 0.16
- ATYR 0.41
- MACD
- CRNT 0.06
- ATYR 0.06
- Stochastic Oscillator
- CRNT 31.55
- ATYR 72.14
About CRNT Ceragon Networks Ltd.
Ceragon Networks Ltd is a wireless transport company in terms of unit shipments and global distribution of its business, providing high-capacity wireless connectivity solutions to global markets across various industries, mainly wireless (mobile) networks service providers. Geographically the company generates the major revenue from India. The company also has presence in North America, Europe, Africa, Asia-Pacific and Middle East, and Latin America. The company's products include IP-50 Platform, IP-20 Platform, Pointlink.
About ATYR aTyr Pharma Inc. Common Stock
aTyr Pharma Inc is a biotherapeutics company engaged in the discovery and development of first-in-class medicines from its proprietary tRNA synthetase platform. The company has concentrated its research and development efforts on a newly discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases. Its primary focus is efzofitimod, a clinical-stage product candidate which targets NRP2 to resolve chronic inflammation that can lead to fibrosis. Efzofitimod has a novel mechanism of action for potentially treating lung inflammation and fibrosis.